Lucica® GA-L Glycated Albumin Assay Kit
Lucica® GA-L Glycated Albumin Assay Kit
复制标题
Lucica® GA-L 糖化白蛋白检测试剂盒
作者：
T. Kohzuma;M. Koga
糖尿病是一个全球性的健康问题，随着糖尿病患者数量的不断增加，严格控制血糖水平对于避免糖尿病潜在的严重并发症至关重要，因此血糖控制监测在糖尿病的管理中至关重要。糖化血红蛋白（HbA 1c）测量是目前最常用的监测糖尿病患者血糖控制的测试。根据糖尿病控制和并发症试验（DCCT）的结果，建议HbA 1c水平<7%，以预防慢性糖尿病并发症的发生和进展。然而，由于红细胞的寿命较长（120天），HbA 1c可能不适合用于评估血糖控制的短期变化。糖化白蛋白（GA）是糖尿病的指标，对血糖变化的敏感性高于HbA 1c。Lucica ® GA-L是一种用于测量GA的新诊断测试。该检测基于酶法，使用无需制备的液体试剂。当监测妊娠期糖尿病、血糖水平不稳定、血红蛋白变异或缩短红细胞寿命的疾病患者的治疗效果时，测量GA水平应提供有关血糖控制的有用信息。
Diabetes mellitus is a worldwide healthcare issue, with the number of diabetic patients continuing to increase.Strict control of plasma glucose levels is critical in order to avoid the potentially severe complications of diabetes, making tests for monitoring of glycemic control essential in the management of the disease.Glycated hemoglobin (HbA1c) measurement is currently the most commonly used test to monitor glycemic control in patients with diabetes. Based on the results of the Diabetes Control and Complications Trial (DCCT), an HbA1c level of <7% has been recommended to prevent the onset and progression of chronic diabetic complications. However, HbA1c may not be suitable for evaluating short-term variations in glycemic control, because of the long lifespan of erythrocytes (120 days).Glycated albumin (GA) is an indicator of diabetes that is more sensitive to change in plasma glucose than HbA1c.Lucica® GA-L is a new diagnostic test for measuring GA. The test is based on an enzymatic method that uses liquid reagents requiring no preparation.Measuring the GA level should provide useful information on glycemic control when monitoring effects of therapy for patients with gestational diabetes, unstable plasma glucose levels, variant hemoglobins or diseases that shorten the lifespan of erythrocytes.
胰岛素和糖尿病。
DOI：
--
发表时间：
1986
期刊：
Transactions of the Association of American Physicians
影响因子：
--
作者：
Mako,ME;Rubenstein,AH
通讯作者：
Rubenstein,AH
影响因子：
158.5
作者：
Nathan, DM;Cleary, PA;Zinman, B
通讯作者：
Zinman, B